CARsgen Therapeutics Holdings Limited (HKG:2171)

HKG:2171 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1,400	1,123	1,479	1,850	2,268	691.28
Short-Term Investments	-	0.88	0.84	1.13	6.31	2,321
Cash & Short-Term Investments	1,400	1,124	1,480	1,851	2,274	3,012
Cash Growth	11.03%	-24.03%	-20.04%	-18.62%	-24.50%	188.31%
Accounts Receivable	11.59	15.55	18.29	-	-	-
Other Receivables	25.82	20.65	14.52	11.82	16.58	49.05
Receivables	37.41	36.2	32.8	11.82	16.58	49.05
Inventory	7.24	7.14	6.93	0.68	-	-
Other Current Assets	13.05	10.46	10.65	9.71	9.72	9.57
Total Current Assets	1,457	1,178	1,530	1,873	2,301	3,071
Property, Plant & Equipment	90.07	97.85	123.95	361.39	441.38	386.19
Other Intangible Assets	1.15	1.15	2.94	8.66	14.48	20.13
Other Long-Term Assets	30.27	15.06	15.87	14.08	6.32	28.46
Total Assets	1,579	1,292	1,673	2,257	2,763	3,506

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accrued Expenses	120.41	132.49	171.37	151.04	137.2	94.71
Current Portion of Long-Term Debt	-	-	20.29	2.52	4.85	219.33
Current Portion of Leases	11.44	12.84	13.44	12.23	17.13	14.03
Current Income Taxes Payable	-	-	-	-	1.34	7.65
Current Unearned Revenue	55.83	54.15	38.66	23.46	6.57	10.14
Other Current Liabilities	-	5.98	10.25	6.97	3.92	43.32
Total Current Liabilities	206.14	205.46	254.01	196.22	171	389.17
Long-Term Debt	-	-	68.85	-	2.52	7.38
Long-Term Leases	42.09	48.34	63.84	70.47	94.94	97.31
Long-Term Unearned Revenue	162.14	184.91	229.63	188.83	21.18	15.12
Other Long-Term Liabilities	76.67	74.09	-	-	-	-
Total Liabilities	487.03	512.8	616.33	455.51	289.65	508.98

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	-	9,302	9,388	9,437	9,430	9,420
Retained Earnings	-	-9,086	-8,988	-8,190	-7,442	-6,550
Comprehensive Income & Other	1,100	567.21	656.5	554.6	484.89	126.63
Total Common Equity	1,100	783.32	1,057	1,802	2,473	2,997
Minority Interest	-7.95	-3.98	-	-	-	-
Shareholders' Equity	1,092	779.34	1,057	1,802	2,473	2,997
Total Liabilities & Equity	1,579	1,292	1,673	2,257	2,763	3,506

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	71.99	61.18	166.42	85.22	119.45	338.05
Net Cash (Debt)	1,328	1,063	1,313	1,766	2,155	2,674
Net Cash Growth	11.44%	-19.06%	-25.61%	-18.06%	-19.42%	183.13%
Net Cash Per Share	2.46	1.93	2.38	3.17	3.91	6.91
Filing Date Shares Outstanding	512.79	538.34	549.41	575.64	572.63	567.54
Total Common Shares Outstanding	512.79	538.34	549.41	575.64	572.63	567.54
Working Capital	1,251	972.63	1,276	1,677	2,130	2,682
Book Value Per Share	2.15	1.46	1.92	3.13	4.32	5.28
Tangible Book Value	1,099	782.17	1,054	1,793	2,459	2,977
Tangible Book Value Per Share	2.14	1.45	1.92	3.11	4.29	5.24
Buildings	-	81.9	81.9	81.32	80.92	36.82
Machinery	-	210.88	216.87	217.89	201.82	176.69
Construction In Progress	-	2.32	12.68	2.13	12.15	152.14
Leasehold Improvements	-	209.87	199.2	200.93	197.47	11.79

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 20, 2026

Data Sources Report a data error